Carey Ng, Ph.D. / MBA
- Dr. Ng is a Managing Director of Mesa Verde and Member of the Investment Committee. Dr. Ng has over ten years investment and operating experience in the biomedical industry, ranging from biotech startups to large biopharmaceutical companies. He currently serves as Board Member and COO at Satiogen Pharmaceuticals, and is a Board Observer at Medipacs, Biomatrica, and Exagen Diagnostics, all Mesa Verde I portfolio companies. Dr. Ng is also a Board Observer at Tokalas, Independa, and Retrosense Therapeutics, the first three Mesa Verde II investments. He was previously a business development executive with Abbott Laboratories. Carey has built an extensive network in Southern California where he received his Doctorate in Molecular & Medical Pharmacology from UCLA and his MBA from the Rady School at UCSD.